News
-
-
-
-
REGULATED PRESS RELEASE
bioMérieux receives U.S. FDA Special 510(k) clearance and CLIA-waiver for its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini
bioMérieux receives U.S. FDA Special 510(k) clearance and CLIA-waiver for its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat Panel Mini, providing fast syndromic testing solutions for healthcare professionals -
-
-
-
-
REGULATED PRESS RELEASE
bioMérieux receives FDA 510(k) clearance of VIDAS® TBI (GFAP, UCH-L1), an innovative test to improve the assessment of patients with mild traumatic brain injury
bioMérieux receives FDA 510(k) clearance of VIDAS TBI (GFAP, UCH-L1), a serum-based test to support the assessment of patients with mild traumatic brain injury, improving patient outcomes. The test uses biomarkers to predict absence of acute intracranial lesions -
